Narrative review / 2012
In clinical trials, cinnamon consumption has produced varying findings, with fasting glucose levels being the only consistently improved measurement.
This review evaluates the evidence and mechanisms of cinnamon for managing insulin resistance, metabolic syndrome, and type 2 diabetes. Human clinical trials have yielded mixed results; while some showed no benefits, others noted improvements in cholesterol, systolic blood pressure, insulin sensitivity, and postprandial glucose. However, the only outcome consistently improved by cinnamon consumption across trials was fasting glucose levels. The authors note it is premature to suggest cinnamon supplementation based on the current evidence, and systematic large-scale clinical trials are needed.
- Study type
- Narrative review
- Who was studied
- Human clinical trial participants and in vitro models
- What was measured
- Fasting glucose, postprandial glucose, insulin sensitivity, cholesterol, blood pressure
THE PAPER
Controversies surrounding the clinical potential of cinnamon for the management of diabetes.
Rafehi H, Ververis K, Karagiannis TC. Diabetes Obes Metab, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.